Integrative molecular concept modeling of prostate cancer progression

被引:715
作者
Tomlins, Scott A.
Mehra, Rohit
Rhodes, Daniel R.
Cao, Xuhong
Wang, Lei
Dhanasekaran, Saravana M.
Kalyana-Sundaram, Shanker
Wei, John T.
Rubin, Mark A.
Pienta, Kenneth J.
Shah, Rajal B.
Chinnaiyan, Arul M. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[7] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1038/ng1935
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Despite efforts to profile prostate cancer, the genetic alterations and biological processes that correlate with the observed histological progression are unclear. Using laser-capture microdissection to isolate 101 cell populations, we have profiled prostate cancer progression from benign epithelium to metastatic disease. By analyzing expression signatures in the context of over 14,000 'molecular concepts', or sets of biologically connected genes, we generated an integrative model of progression. Molecular concepts that demarcate critical transitions in progression include protein biosynthesis, E26 transformation-specific (ETS) family transcriptional targets, androgen signaling and cell proliferation. Of note, relative to low-grade prostate cancer (Gleason pattern 3), high-grade cancer (Gleason pattern 4) shows an attenuated androgen signaling signature, similar to metastatic prostate cancer, which may reflect dedifferentiation and explain the clinical association of grade with prognosis. Taken together, these data show that analyzing gene expression signatures in the context of a compendium of molecular concepts is useful in understanding cancer biology.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 50 条
[31]   Does the ribosome translate cancer? [J].
Ruggero, D ;
Pandolfi, PP .
NATURE REVIEWS CANCER, 2003, 3 (03) :179-192
[32]   Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma [J].
Sato, K ;
Qian, JQ ;
Slezak, JM ;
Lieber, MM ;
Bostwick, DG ;
Bergstralh, EJ ;
Jenkins, RB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) :1574-1580
[33]   A module map showing conditional activity of expression modules in cancer [J].
Segal, E ;
Friedman, N ;
Koller, D ;
Regev, A .
NATURE GENETICS, 2004, 36 (10) :1090-1098
[34]   Gene expression correlates of clinical prostate cancer behavior [J].
Singh, D ;
Febbo, PG ;
Ross, K ;
Jackson, DG ;
Manola, J ;
Ladd, C ;
Tamayo, P ;
Renshaw, AA ;
D'Amico, AV ;
Richie, JP ;
Lander, ES ;
Loda, M ;
Kantoff, PW ;
Golub, TR ;
Sellers, WR .
CANCER CELL, 2002, 1 (02) :203-209
[35]   Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer [J].
Stanbrough, M ;
Bubley, GJ ;
Ross, K ;
Golub, TR ;
Rubin, MA ;
Penning, TM ;
Febbo, PG ;
Balk, SP .
CANCER RESEARCH, 2006, 66 (05) :2815-2825
[36]   Statistical significance for genomewide studies [J].
Storey, JD ;
Tibshirani, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9440-9445
[37]   In silico dissection of cell-type-associated patterns of gene expression in prostate cancer [J].
Stuart, RO ;
Wachsman, W ;
Berry, CC ;
Wang-Rodriguez, J ;
Wasserman, L ;
Klacansky, I ;
Masys, D ;
Arden, K ;
Goodison, S ;
McClelland, M ;
Wang, YP ;
Sawyers, A ;
Kalcheva, I ;
Tarin, D ;
Mercola, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :615-620
[38]   Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles [J].
Subramanian, A ;
Tamayo, P ;
Mootha, VK ;
Mukherjee, S ;
Ebert, BL ;
Gillette, MA ;
Paulovich, A ;
Pomeroy, SL ;
Golub, TR ;
Lander, ES ;
Mesirov, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15545-15550
[39]   Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN [J].
Sumitomo, M ;
Iwase, A ;
Zheng, R ;
Navarro, D ;
Kaminetzky, D ;
Shen, RQ ;
Georgescu, MM ;
Nanus, DM .
CANCER CELL, 2004, 5 (01) :67-78
[40]   TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer [J].
Tomlins, SA ;
Mehra, R ;
Rhodes, DR ;
Smith, LR ;
Roulston, D ;
Helgesson, BE ;
Cao, XH ;
Wei, JT ;
Rubin, MA ;
Shah, RB ;
Chinnaiyan, AM .
CANCER RESEARCH, 2006, 66 (07) :3396-3400